Nordhealth AS Cash Flow Conversion Efficiency
Nordhealth AS cash flow conversion efficiency. Based on the latest financial reports, Nordhealth AS (NORDH) has a cash flow conversion efficiency ratio of -0.008x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-498.00K ≈ $-52.40K USD) by net assets (Nkr61.56 Million ≈ $6.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Nordhealth AS for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Nordhealth AS (2020–2025)
Cash flow conversion efficiency of Nordhealth AS from 2020 to 2025. This chart illustrates how Nordhealth AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NORDH share price today for real-time trading data and today's change.
Nordhealth AS Cash Flow Conversion Ratio Explained
Nordhealth AS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Nordhealth AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nordhealth AS ranked by their cash flow conversion efficiency. Review cash generation quality of Nordhealth AS to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cyprium Metals Ltd
AU:CYM
|
-0.068x |
|
Swarmer, Inc Common Stock
NASDAQ:SWMR
|
N/A |
|
Tah Kong Chemical Industrial
TWO:4706
|
0.003x |
|
Sinclair Gold Ltd
AU:SGC
|
-0.077x |
|
Even Construtora e Incorporadora S.A
SA:EVEN3
|
0.005x |
|
Southern Petrochemicals Industries Corporation Limited
NSE:SPIC
|
0.592x |
|
Cornish Metals Inc.
V:CUSN
|
-0.014x |
|
Hanpin Electron Co Ltd
TW:2488
|
-0.019x |
Annual Cash Flow Conversion Efficiency for Nordhealth AS (2020–2025)
The table below shows the annual cash flow conversion efficiency of Nordhealth AS from 2020 to 2025. Also see Nordhealth AS balance sheet assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr61.56 Million ≈ $6.48 Million |
Nkr719.00K ≈ $75.66K |
0.012x | -53.46% |
| 2024-12-31 | Nkr73.63 Million ≈ $7.75 Million |
Nkr1.85 Million ≈ $194.46K |
0.025x | +139.77% |
| 2023-12-31 | Nkr82.77 Million ≈ $8.71 Million |
Nkr-5.22 Million ≈ $-549.61K |
-0.063x | +4.61% |
| 2022-12-31 | Nkr98.63 Million ≈ $10.38 Million |
Nkr-6.53 Million ≈ $-686.62K |
-0.066x | -236.08% |
| 2021-12-31 | Nkr114.51 Million ≈ $12.05 Million |
Nkr5.57 Million ≈ $585.81K |
0.049x | -95.67% |
| 2020-12-31 | Nkr4.95 Million ≈ $521.30K |
Nkr5.57 Million ≈ $585.81K |
1.124x | -- |
About Nordhealth AS
Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, Germany, and internationally. Its products include Provet Cloud, a veterinary practice management software (PMS); Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychothera… Read more